BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Condition(s):Metastatic Colorectal CarcinomaLast Updated:September 29, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Colorectal CarcinomaLast Updated:September 29, 2022Recruiting
Condition(s):Esophageal Cancer; Esophageal AdenocarcinomaLast Updated:June 24, 2022Recruiting
Condition(s):Acute Alcoholic HepatitisLast Updated:January 25, 2019Terminated
Condition(s):Leukemia, Myeloid, AcuteLast Updated:May 21, 2021Completed
Condition(s):Pancreatic CancerLast Updated:August 24, 2016Terminated
Condition(s):Pancreatic CancerLast Updated:February 12, 2018Completed
Condition(s):High Grade GliomaLast Updated:April 25, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:April 24, 2018Unknown status
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:March 5, 2024Active, not recruiting
Condition(s):Colorectal Cancer; Liver Metastases; Genetic ChangeLast Updated:September 29, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.